Edition:
United States

People: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

132.49USD
27 Mar 2017
Change (% chg)

$-0.02 (-0.02%)
Prev Close
$132.51
Open
$132.00
Day's High
$132.62
Day's Low
$131.92
Volume
266,401
Avg. Vol
379,731
52-wk High
$133.56
52-wk Low
$104.63

Doliveux, Roch 

Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He served as Former Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, from 2005 through 2014. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation. He is Chairman of the GLG Healthcare Institute and chairs the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium. Dr. Doliveux has extensive experience in life science and healthcare companies, including product management, global marketing, research and development, and strategic and organizational change management. His exposure to business in many geographies and cultures is very valuable as Stryker seeks to expand its global presence.

Basic Compensation

Total Annual Compensation, USD 115,000
Restricted Stock Awards, USD 85,656
Long-Term Incentive Plans, USD --
All Other, USD 87,840
Fiscal Year Total, USD 288,496

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Lobo

10,470,400

Glenn Boehnlein

--

Lonny Carpenter

3,141,340

David Floyd

3,399,400

Graham Mclean

--

Timothy Scannell

4,397,060
As Of  30 Dec 2015